Next-generation sequencing identifies equine cartilage and subchondral bone miRNAs and suggests their involvement in osteochondrosis physiopathology by unknown
Desjardin et al. BMC Genomics 2014, 15:798
http://www.biomedcentral.com/1471-2164/15/798RESEARCH ARTICLE Open AccessNext-generation sequencing identifies equine
cartilage and subchondral bone miRNAs and
suggests their involvement in osteochondrosis
physiopathology
Clémence Desjardin1,4*, Anne Vaiman1, Xavier Mata1, Rachel Legendre1, Johan Laubier1, Sean P Kennedy2,
Denis Laloe1, Eric Barrey1, Claire Jacques3, Edmond P Cribiu1 and Laurent Schibler1Abstract
Background: MicroRNAs (miRNAs) are an abundant class of small single-stranded non-coding RNA molecules
ranging from 18 to 24 nucleotides. They negatively regulate gene expression at the post-transcriptional level and
play key roles in many biological processes, including skeletal development and cartilage maturation. In addition,
miRNAs involvement in osteoarticular diseases has been proved and some of them were identified as suitable
biomarkers for pathological conditions. Equine osteochondrosis (OC) is one of the most prevalent juvenile osteoarticular
disorders in horses and represents a major concern for animal welfare and economic reasons. Its etiology and
pathology remain controversial and biological pathways as well as molecular mechanisms involved in the
physiopathology are still unclear. This study aims to investigate the potential role of miRNAs in equine
osteochondrosis (OC) physiopathology.
Short-read NGS technology (SOLID™, Life Technologies) was used to establish a comprehensive repertoire of
miRNA expressed in either equine cartilage or subchondral bone. Undamaged cartilage and subchondral bone
samples from healthy (healthy samples) and OC-affected (predisposed samples) 10-month Anglo-Arabian foals
were analysed. Samples were also subjected or not to an experimental mechanical loading to evaluate the role
of miRNAs in the regulation of mechano-transduction pathways. Predicted targets of annotated miRNAs were
identified using miRmap.
Results: Epiphyseal cartilage and subchondral bone miRNome were defined, including about 300 new miRNAs.
Differentially expressed miRNAs were identified between bone and cartilage from healthy and OC foals, as well as
after an experimental mechanical loading. In cartilage, functional annotation of their predicted targets suggests a
role in the maintenance of cartilage integrity through the control of cell cycle and differentiation, energy
production and metabolism as well as extracellular matrix structure and dynamics. In bone, miRNA predicited
targets were associated with osteoblasts and osteoclasts differentiation, though the regulation of energy
production, vesicle transport and some growth factor signaling pathways.
Conclusion: Taken together, our results suggest a role of miRNAs in equine OC physiopathology and in the cellular
response to biomechanical stress in cartilage and bone. In silico target prediction and functional enrichment analysis
provides new insight into OC molecular physiopathology.
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MicroRNAs (miRNAs) are an abundant class of small
single-stranded non-coding RNA molecules of 18 to 24
nucleotides generated by a sequential processing of long
RNA transcripts by two specific RNAse III proteins:
Dicer and Drosha [1]. Studies performed during the past
decade have led to the discovery of many miRNAs in al-
most all organisms [2]. Over 8000 predicted miRNAs
from plants, animals and viruses are currently described
in miRBase, the reference database. It has been shown
that miRNAs negatively regulate gene expression at the
post-transcriptional level by targeting specific mRNAs for
cleavage or translational repression trough the RNA-
induced silencing complex (RISC) [3]. They play key roles
in many biological processes, including development, cell
proliferation, differentiation as well as apoptosis and have
been shown to be involved in a number physiopathologi-
cal processes [4].
Analysis of cartilage-specific Dicer-knock-out (KO)
mice [5] revealed a crucial role of miRNAs in cartilage
development and integrity. However, a comprehensive
identification of miRNAs expressed in cartilage and bone
and their precise role is still unclear. Recent studies
highlighted the role of some miRNAs in endochondral
ossification [6], chondrocytes differentiation [7], regulation
of bone remodeling [8] and osteoblast and osteoclast dif-
ferentiation and functions [9-11]. In addition, miRNA ex-
pression profiling performed on bovine articular cartilage
suggested their involvement in mechano-transduction
pathway and in the maintenance of articular cartilage
homeostasis [12]. In line with their role in cartilage matu-
ration and bone development, miRNAs are now recognized
as key players in osteoarthritis (OA) physiopathology
[13,14] and may prove to be involved in other osteoarticu-
lar diseases [15]. For example, it has been demonstrated
that mir-27b regulates a protein involved in MEC turn-
over, the Matrix Metalloproteinase 13 (MMP-13), in both
normal and OA human chondrocytes. This result suggest
that an abnormal expression of mir-27b may contribute to
OA development [16]. Furthermore, some miRNAs have
been identified as biomarkers for pathological conditions
including OA [17].
Most recently, there has been growing interest in using
next-generation sequencing (NGS) to catalog small RNAs
in a variety of tissue. The aim of our study was to use
short-read NGS technology (SOLID™, Life Technologies)
to establish a comprehensive repertoire of miRNA
expressed in either equine cartilage or subchondral
bone and to investigate their potential role in equine
osteochondrosis (OC). This juvenile osteoarticular disease
leads to joint swelling, stiffness and varying degrees of
lameness [18-20]. OC is one of the most prevalent deve-
lopmental orthopedic diseases in equine population and
constitutes a major concern in terms of animal welfare aswell it economic impact [21]. Its etiology and pathology
are still unclear, due to the confusion regarding the defin-
ition of the disease and the lack of understanding of pri-
mary lesions formation [22]. Clearly, there is a need for a
better understanding of OC molecular physiopathology in
order to refine nosological entities.
Here, we analysed undamaged cartilage and subchon-
dral bone from healthy (healthy samples) and OC-affected
(predisposed samples) foals, with and without an experi-
mental mechanical loading. This was performed with the
aim of exploring the role of miRNAs in the constitutive
defects associated with OC development, as well as in
regulating mechano-transduction pathways. This work
made it possible to define, for the first time to our know-
ledge, the comprehensive epiphyseal cartilage and sub-
chondral bone miRNome, including about 300 new
putative miRNAs. Furthermore, we highlighted miRNAs
associated with both OC status and mechanical loading,
suggesting that miRNAs may be involved in OC physiopa-
thology as well as in the cellular response to biomechan-
ical stress. Some differentially expressed miRNA identified
by our work may later prove to be valuable diagnostic bio-
markers that could help refining the nosological entities.
Methods
Animal care committee
The experimental protocol was reviewed and approved
under the number 0964 by the Animal Care Committee
of VetAgro Sup, which abides by the requirements of the
directive 86/609 of the European Community Council.
Samples collection and experimental design
The study was based on 37 Anglo-Arabian foals obtained
from a unique stallion known to have OC-affected foals in
his progeny (Figure 1). The osteo-articular status of the
mares was not extensively ascertained, but none was diag-
nosed as OC-affected based on clinical examination.
Foals were bred at the experimental station of the
French National Stud (Station IFCE of Chamberet) to re-
duce genetic and environmental variability. Mare-foal cou-
ples were managed on swivel pastures until the end of the
grass season. The osteo-articular status of each foal was
determined between six to seven months of age to reliably
identify OC lesions. Horses were subjected to a clinical
examination consisting in a qualitative visual assessment
for lameness, trauma, skin anomalies and joint effusion.
An X-ray examination of fetlock, tarsocrural and stifle
joints of each foal was then performed and images were
evaluated for the presence of OC signs. If irregularities or
anomalies were noted, additional X-rays were taken to
confirm the lesion. Foals were considered healthy if the
clinical exam was normal without ambiguity and if X-rays
did not reveal any sign of osteo-articular irregularities.
Three healthy and three OC-affected (at least one lesion
Figure 1 Experimental design. Three healthy foals and three OC-affected foals presenting lesion on the hock were divided in two groups.
Healthy (H) and OC-predisposed (OC) cartilage and bone samples were pieced on the stifles. Samples were then subjected (_L) or not (_UL) to a
24-hours experimental loading. Short-read NGS technology (SOLID™, Life Technologies) was performed to define the cartilage and sub-chondral
bone miRnomes. Three comparisons were used: between healthy and OC predisposed samples (H vs OC) to test the hypothesis of a constitutive
defect, between healthy loaded and unloaded samples (H_L vs H_UL) to evaluate the role of miRNA in the response to biomechanical stress and
between healthy and OC-predisposed samples loaded (H_L vs OC_L) to test the hypothesis of a impaired response to mechanical loaded in
OC-affected foals.
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months by lethal intravenous injection of T61 (Embutra-
mide), a sedative drug used for euthanasia in veterinary
medicine. All joints were macroscopically examined at
necropsy to ensure the healthy status and confirm radio-
logic diagnosis. Cartilage and bone cylindrical explants
were obtained from the stifle (healthy joint) using a 12-
mm punch. Samples were collected on the same location
in the middle of the trochlea to avoid technical bias due to
sample location in the joint. Explants including epiphyseal
cartilage and about 5 mm of the soft underlying bone
(considered as subchondral bone) were washed in PBS
and placed in DMEM culture medium for subsequent
mechanical-loading experiments or flash frozen in liquid
nitrogen for subsequent RNA-seq analysis.
OC-lesions were also collected, fixed for 24 hours in a
solution of 4% paraformaldehyde, decalcified in EDTA
10% pH 8.8 solution for one month before being embed-
ded in paraffin and sectioned (5 μm). Sections were
stained with safranin-O and light green (Additional file 1).
Experimental loading
Harvested cartilage explants were placed into individual
compression wells of Biopress culture plates (Flexercell
International) in 1.5 ml of culture medium (DMEM, con-
taining penicillin-streptomycin 1%, glutamine 2%, albumin0.1% and Hepes 30 mM). All experiments were performed
at 37°C, under ambient atmosphere. A compressive stress
was applied to individual samples by the Flexercell FX-
4000C system (sinusoidal waveform at 0.5 Hz, 1MPa,
24h00) whereas the control explants stayed in unloaded
conditions, as previously described [23].
Protaglandin E2 (PGE2) production was measured in
the media by a high sensitivity commercially available
enzyme immunoassay kit (Cayman Chemical), as previ-
ously described [24].
Sequencing
miRNA was extracted from ~150mg of tissue (bone and
cartilage) which had been previously frozen at −80°C
post-necropsy and subsequently stored in liquid nitro-
gen. The mirVana™ miRNA Isolation Kit (Ambion, Life
Technologies) was used to extract in parallel Total RNA
and small RNA (smRNA) from cartilage following the
manufacturer’s protocol. Total RNA was purified from
bone using the miRNeasy Mini kit (Qiagen) and the
RNeasy MinElute Cleanup kit (Qiagen) for enrichment
of small RNA (<200 nt) following the manufacturer’s
protocol. Total RNA quality was assessed using an
Agilent Bioanalyzer 2100 (Agilent Technologies) loaded
with a RNA 6000 Nano Kit. The concentrations of
smRNA were determined using a NanoDrop ND-1000
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mined using the Bioanalyzer 2100 loaded with a RNA
6000 Nano Kit. Approximately 190ng of miRNA extracted
from bone and 70ng from cartilage was used for library
constructions following the protocol for the SOLiD® Total
RNA-Seq Kit (Applied Biosystems, Life Technologies). A
total of 30 libraries were prepared: 15 for cartilage and 15
for bone. Among these 15 libraries, 3 were prepared from
healthy cartilage/bone from healthy horses, 3 from healthy
cartilage/bone from OCD horses, 3 from healthy cartilage/
bone from healthy horses after 24H of compression, 3 from
healthy cartilage/bone from OCD horses after 24H of com-
pression and 3 from healthy cartilage/bone from healthy
horses in the culture medium used during compression.
Briefly, the small RNAs were hybridized and ligated
with SOLiD™ Adaptor Mix, a reverse transcription was
performed and the cDNAs were purified using the
MinElute PCR purification kit (Qiagen). The 60–80 base
pair fraction of the cDNA was excised from a 10% acryl-
amide gel stained with SYBR Gold (Invitrogen, Life
Technologies) and an amplification was realized by PCR
(95°C - 1 min, 18 × (95°C -30s, 62°C – 30 s, 72°C – 30 s),
72°C – 7 min) using the SOLiD 5’ PCR primer and a 3’
library-specific barcoded SOLiD primer. The amplified
DNA was purified using the Purelink PCR micro kit (Invi-
trogen, Life Technologies) and the 110–130 bp region was
excised from a 6% acrylamide gel stained with SYBR Gold
(Invitrogen, Life Technologies). The yield and size distri-
bution of the amplified DNA were assessed and pools of
three different horses were made to decrease the effect of
individual variability. Libraries were processed on the
SOLiD EZBead system for template bead preparation
prior to sequencing.
Small RNA libraries were sequencing on a SOLiD
5500XL Series Genetic Analysis System at the Meta-
quant Platform (INRA, Jouy-en-Josas). 350 million 50-nt
reads were generated over the thirty libraries.
Sequence data deposition
Raw sequence data and protocol details were submitted to
the ArrayExpress database (http://www.ebi.ac.uk/arrayex-
press/) through the Annotare 2.0 submission tool. The
experiment has been assigned accession number E-
MTAB-2736.
Adaptor trimming and reads mapping
Adaptors in color space (5’-330201030313112312-3’)
were removed by Cutadapt (version 0.9.5), permitting
two mismatches over reads between 17 and 26 nucleo-
tides. Read mapping was performed using Bowtie (ver-
sion 0.12.7) with color space options, in v- alignment
mode, permitting 2 mismatches. Uniquely mapping
reads and reads with <6 total alignments were retained.
In the second case, all alignments were reported in thebest-to-worst order (best option). Reads with >6 align-
ments were removed. Mapped reads overlapping with
known non-coding RNAs (except miRNAs) obtained from
RFAM (http://rfam.sanger.ac.uk/) were also discarded.
Loci detection and quantification
Samtools (http://samtools.sourceforge.net/) was used to
convert the SAM files to BAM files and Bedtools (http://
code.google.com/p/bedtools/) to retrieve information
from the alignment file and extract it into a *.wig file
with all positions available (chromosome, start, stop) for
each read or locus mapped to the reference genome
(“genomeCoverageBed”). The candidate loci were then
used as guidelines for excising potential miRNAs precur-
sor sequences from the horse genome. Two potential se-
quences were excised, one at −10 bp and +50bp centered
on the island and another at -50bp and +10bp, to simulate
the 5p and 3p position of the potential miRNA. Each po-
tential precursor sequence was passed to RNAfold tool
(Vienna package, version 1.8.5) to predict secondary struc-
tures and detect potential hairpin structure. In-house Perl
scripts were used to count reads in each candidate loci for
all samples.
miRNAs annotation
Equine mature miRNAs annotations were extracted
from the miRBase database (http://www.mirbase.org/).
In order to extend annotations, human, bovine, dog, pig
and mouse miRNAs precursor sequences were aligned
to the horse genome by BLAST (version2.2.25). Hits
with a bit score higher than 90 were conserved and
IntersectBed (tool of BedTools) was used to annotate
each candidate miRNA. Manual cleaning and curation
was performed to correct or improve nomenclature.
For putative new miRNAs, we applied the follow filter-
ing criteria: a size between 17 and 29 bases, a count
greater than or equal to 1000 in at least one experimen-
tal library and a free energy of the secondary structure
calculated by RNAfold lower than −20 kcal/mol, which
is characteristic of known miRNAs RNAfold scores.
MapMi (http://www.ebi.ac.uk/enright-srv/MapMi/) was
used to query orthologs in five other mammalian species
(cattle, pig, humans, dog and mouse).
Statistical analysis
Statistical analysis for determining differential expression
was performed with R v2.15.0 [25] using the Bioconduc-
tor package DESeq version 1.0.0 [26]. DESeq utilizes a
negative binomial distribution for modeling read counts
per miRNA and implements a method for normalizing
the counts. This normalization procedure uses the li-
brary median of the ratios between the read count and
the geometric mean of each gene as a scaling factor for
each library. The p-values were adjusted for multiple
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A comprehensive description of miRNA expression pat-
terns was performed by principal component analysis
(PCA) and between-class analysis (PCA of the table of
the group means, BCA). The R software (version 1.4.17)
was used with the R package ade4 (Version 1.5-2).
Validating RNA-Seq data using Taqman qPCR technology
Total RNA was extracted from cartilage (mirVana™
miRNA Isolation Kit Ambion, Life Technologies) and
bone (miRNeasy Mini Kit, Quiagen) samples according
to the instructions of the respective extraction kits. For
each samples, 10 ng of total RNA were obtained. The
RNA was reverse transcribed into cDNA using the add-
itional poly(A) tail reaction method according to the in-
structions of the reverse transcription kit (TaqMan®
MicroRNA Reverse Transcription Kit, Applied Biosys-
tems, Life Technologies). The qPCR reaction was per-
formed according to the instructions of the qPCR kit
(TaqMan® Universal Master Mix II, Applied Biosystems,
Life Technologies) and a Mastercycler Ep Realplex ap-
paratus (Eppendorf ). For each cartilage and bone sam-
ples, reactions were performed in triplicate. Results were
analysed using the qBase + data analysis software and
expressed as normalized relative quantity (NRQ) [28]
based on one reference gene for each tissue. Reference
genes were chosen based on RNA-seq results, as having
the smallest variations between all samples from each
tissue.
Identification and functional annotation of miRNAs
predicted targets
The miRmap web tool (http://mirmap.ezlab.org/app/)
was used to query for miRNAs predicted targets [29].
For each miRNAs of interest, a comprehensive target
prediction was obtained. We considered only predicted
targets having a miRmap score above 90 and retained, at
most, the first 500 with the best score. In addition, these
targets were also filtered based on known expression
patterns in cartilage and bone, respectively. Functional
annotation was performed using PANTHER (http://
www.pantherdb.org/) [30] and comparative statistical en-




Two explants from each horse were subjected to com-
pressive stress using a Flexercell FX-4000C system,
whereas two other explants were left in unloaded condi-
tions to serve as controls. Prostaglandin E2 (PGE2) release
in the media (pg/mg/ml of explant) was measured to
evaluate compression efficiency. In agreement with previ-
ous data obtained on mouse costal cartilage explants [31],a significant two-fold induction was observed, on average,
between compressed and uncompressed samples (Supple-
mentary data). No significant differences were observed
between compressed predisposed and healthy samples.
Identification and characterization of miRNAs in equine
bone and cartilage tissues
Total RNA and small RNA were extracted in parallel.
RIN between 7.5 and 8 were observed for cartilage sam-
ples, whereas RIN in the range 8.5 to 9 were obtained
for bone samples. Thirty libraries were built and se-
quenced using the SOLID™ technology, generating 9 to
15 million reads for each library. All sequence data can
be retrieved from the ArrayExpress database under ac-
cession number E-MTAB-2736. After adaptor trimming
and size selection, about 70% of these reads were
mapped to the EquCab2 horse genome for each sample,
defining about 53998 to 97964 regions. Among these re-
gions, 327 and 329 in cartilage and bone, respectively,
overlapped with previously known mammalian miRNA
(Additional file 2: Table S1-A, and Additional file 3:
Table S1-B). Secondary structure analysis identified 282
and 293 putative new miRNAs in cartilage and bone, re-
spectively (Supplementary data). Only regions with a
genomic coverage greater than 2 were kept for further
analysis.
We elaborated a set of 609 expressed miRNAs in car-
tilage and 622 miRNAs in bone. 561 miRNAs were
found to be expressed in both tissues.
About 300 putative new miRNAs were identified based
on their expression level and RNAfold score. Existing
miRNA precursor sequences were searched using
MapMi in five other mammalian genomes (cattle, pig,
humans, dog and mouse), identifying likely orthologs in
at least one species for 163 miRNAs.
Differential miRNAs expression analysis
A between-class correspondence analysis was performed
for each tissue, showing a good discrimination between
each experimental condition (Figure 1): normal native
cartilage or bone from healthy (H) versus affected (OC)
foals, before (H_UL) versus after (H_L, OC_L) an experi-
mental 24h mechanical loading (Figure 2 A-B). Differen-
tial analyses were also performed for each tissue and
each condition. Loaded and unloaded samples could be
efficiently discriminated, confirming the efficiency of the
experimental compression.
Expression levels of miRNA in normal bone and cartil-
age from healthy and predisposed samples were compared
to determine the potential role of miRNAs in equine OC
physiopathology. This analysis highlighted 49 miRNAS
differentially expressed in cartilage (including 5 annotated)
and 41 miRNAs (8 annotated) in bone (Figure 3-A,B,C).
In cartilage, 3 miRNA were found to be up-regulated in
Figure 2 Between Class Analysis (BCA) based on A- cartilage and B- bone miRnomes. BCA succeed in discriminating between healthy
samples (H) and predisposed samples of OC-affected foals (OC), as well as healthy samples loaded (H_L) and unloaded (H_UL) in both cartilage
and bone. This suggests that miRNA may be involved in OC physiopathology and biological response to mechanical loading. In contrast, BCA
does not well discriminate between healthy samples loaded (H_L) and OC predisposed samples loaded (OC_L) in cartilage and bone. This may
prove that biomechanical response is not disrupted in cartilage and bone predisposed samples of OC-affected foals.
Figure 3 Number of differentially expressed miRNAs in cartilage A- and bone B- according to p-value (0,1; 0,05; 0,01) and comparisons
performed: between healthy and OC predisposed samples (H vs OC); between healthy loaded and unloaded samples (H_L vs H_UL);
between healthy and OC-predisposed samples loaded (H_L vs OC_L). C- Annotated miRNAs differentially expressed between healthy and
predisposed cartilage and bone. In cartilage, 5 annotated miRNAs were down-regulated whereas in bone, 8 annotated miRNAs were up-
regulated. Those data suggest a role of miRNAs in OC physiopathology.
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and only a single miRNA species was found to be down-
regulated (Figure 3-A, B,C). Six differentially expressed
miRNAs (three in each tissue) were also studied by qPCR
on a panel of 5 OC-affected and 5 healthy foals to confirm
RNA-seq results. Expression and differential trends were
confirmed in all cases, but 2 miRNAs failed to reach stat-
istical significance (supplementary data).
We also investigated changes in miRNA expression in-
duced by mechanical stress. Nineteen differentially
expressed miRNAs were identified in cartilage (2 anno-
tated) and 21 in bone (2 annotated). Among these, 12
miRNAs were up-regulated in cartilage and 9 in bone
(Figure 3-A-B).
Finally, in order to test the hypothesis of an impaired
response to biomechanical stress in OC horses, miRNA
expression was compared in normal bone and cartilage
from OC versus healthy foals after experimental loading.
In cartilage, 15 miRNAs (1 annotated) were modulated,
7 of these being up-regulated (Figure 3-A). In bone, 28
miRNAs (2 annotated) were differentially expressed, in-
cluding 24 up-regulated and 1 down-regulated in OC
foals (Figure 3-B).
Identification and functional annotation of miRNAs
predicted targets
Predicted targets of annotated miRNAs differentially
expressed in bone and cartilage of OC foals were queried
using miRmap [29]. About 2400 putative targets could
be identified, ranging from 42 to 250 targets for each
miRNAs of interest in cartilage and from 51 to 250 in
bone (177 and 192 targets on average in cartilage and
bone, respectively). Global functional annotation using
PANTHER showed that predicted targets were primarily
involved in cell cycle, cell adhesion, energy production
and metabolism, as well as cell communication, adhe-
sion and transport (Figure 4A and B). Functional enrich-
ment analysis in cartilage highlighted genes primarily
associated with skeletal phenotypes and involved in cell
cycle and differentiation, energy production and metab-
olism (ATPase and GTPase activity, carbohydrate meta-
bolic process, macromolecule biosynthesis), proteins
modifications, folding and transport (protein modifica-
tion process, transport, endoplasmic reticulum unfolded
protein response, proteolysis), cellular homeostasis,
extracellular matrix structure and dynamics (collagen,
chondroitin sulfate and glycosaminoglycan catabolic
process, regulation of metalloendopeptidase activity),
cellular organization (cytoskeleton), ossification as well
as regulation of Wnt and fibroblast growth factor signal-
ing pathways (Additional file 2).
In bone, genes were also associated with skeleton
development and morphogenesis, as well as osteo-
blasts and osteoclasts differentiation (Additional file 3).Enriched functions included energy production (Ras
and Rab GTPase, mitochondria), calcium homeostasis
(endoplasmic reticulum calcium ion homeostasis, cal-
cium channel activity), lipid biosynthesis and transport,
vesicle transport (vesicle organization, vesicle-mediated
transport, Golgi to ER retrograde vesicle-mediated
transport, endocytosis, exocytosis), as well as regulation
of growth factor signaling pathways (fibroblast growth
factor, insulin-like growth factor I, transforming growth
factor beta).
Discussion
In this study we characterized miRNA expression pro-
files in equine epiphyseal cartilage and subchondral bone
using NGS analysis. We identified 609 and 622 miRNAs
expressed in cartilage and bone, respectively, including
about 300 novel miRNAs. Recently, Sun et al., described
the use of a Solexa-based deep sequencing approach to
identify miRNAs profiles of articular cartilage from rat
femoral head cartilage. This study made it possible to
highlight 310 known miRNAs as well as 86 novel miR-
NAs candidates [32]. Since 215 miRNA are found in
common with the present study, our results extend the
repertoire of miRNA expressed in cartilage by adding
111 additional miRNAs. We provide a comprehensive
repertoire of miRNAs expressed in both cartilage and
bone samples collected in vivo. In particular, our results
highlighted numerous new putative highly expressed
miRNAs based on a high confidence RNA-fold score.
Most of these also display orthologous precursor se-
quences in at least one other mammalian genome. Fur-
thermore, they were found to be modulated between
healthy and OC-affected horses, providing support for
the hypothesis that these sequences do not account for
experimental artifacts, but rather may represent genuine
miRNAs or smallRNAs. Such a large number of new pu-
tative miRNAs may be due to the lack of studies and
data specifically targeting cartilage and bone miRnome.
Equine osteochondrosis is the most common develop-
mental osteoarticular disorder in equine populations
leading to pain and lameness. Primary lesions are
thought to results from a focal disruption of endochon-
dral ossification, leading to cartilage retention into sub-
chondral bone. Several studies have suggested that
primary lesions result from an initial dyschondroplasia
associated with an impaired differentiation of chondro-
cytes [22,33] whereas other studies have supported the
hypothesis of an initial disruption of canal blood supply
leading to the formation of necrotic cartilage areas
[34-36]. Here, our miRNome analysis agrees with the hy-
pothesis of a constitutive defect leading to impaired car-
tilage maturation. Indeed, our study was focused on
undamaged samples collected on stifle from healthy foals
and foals affected by OC lesions on hock. Differential
Figure 4 Molecular functions of targets of miRNAs differentially expressed between healthy and OC-affected foals in cartilage
(A, upper panel) and bone (B, lower panel). The diagrams show the proportion of modulated miRNAs targets belonging to the most
significant functional annotations derived from the Gene Ontology (GO).
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cartilage and bone, respectively. Interestingly, several
gene mapping programs have been initiated worldwide
in different breeds and several quantitative trait loci
(QTL) regions have been identified (for review see [37]).
On these regions, two were found to contain a new
miRNA differentially expressed in cartilage (new-eca-
mir-696 and new-eca-mir-754) and one overlap with the
location of eca-mir-1249, which has been shown to be
modulated in bone (Additional file 4).
In cartilage, predicted target genes were found associ-
ated with known functions and mechanisms involved in
maintenance of cartilage integrity. For example, the bal-
ance between catabolic and anabolic processes plays a
critical role in cartilage homeostasis [38]. It has been
shown that several miRNAs including mir-140, mir-
199a, mir-193 and mir-29a/29b may be involved in car-
tilage anabolic and catabolic regulation by regulating the
expression of key genes involved in those process such
as MMP13, Adamts-5 or Col2A1 (for review see [39]).
Following these results, our data suggest that differen-
tially expressed miRNAs regulate genes involved in
macromolecule metabolism and protein folding and
transport. This may also reflect a modification of car-
tilage turn-over in OC foals. Furthermore, chondrocyte
energy metabolism plays a major role in chondrocyte
development, maturation and mineralization process
[40-42]. Likewise, actin cytoskeleton, which plays a
major role in chondrocyte hypertrophic differentiation
[43], was highlighted in our data. Taken together, our
results suggest that down-regulation of miRNAsexpression in OC predisposed foals may alter pathways
crucial for cartilage maturation, leading to an abnormal
extracellular cartilage matrix synthesis. Interestingly,
extracellular matrix changes were observed in OC-
affected horses, often associated with a disruption of car-
tilage canals [33,44-46]. Thus, our findings are consist-
ent with a role of miRNAs in cartilage genetic
susceptibility to equine OC.
Likewise, in bone, miRNAS target genes were found
associated with functions essential for bone development
and remodeling, as well as bone cell differentiation and
activation. For instance, energy production and meta-
bolisms are undoubtedly essential for proper bone tissue
development. Indeed, ATP is essential for osteoclasts
to generate the acidic environment required for so-
lubilization of the alkaline salts and digestion of the or-
ganic bone matrix [47], and is involved in osteoblast
differentiation and activation [48]. In addition, several
studies have demonstrated that Rab GTPases, a family of
proteins involved in membrane traffic, play an key role
for osteoclasts function, in particular for the polarized
transport of acidic vesicles of the endocytic/lysosomal
pathway required for formation of the ruffled border (for
review see [49]). Likewise, lipids, especially cholesterol,
are essential for osteoblasts and osteoclasts development
(for review see [50]). Consistent with the known role
of miRNAs in the control of bone remodeling (for
review see [8]) and their involvement in key regulation
pathways of bone formation and remodeling such as
BMP-signaling pathway (mir-133, mir-135) [51] and
Wnt-signaling pathway (mir-29a) [52], miRNA predicted
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several signaling pathways (FGF, TGFb, IGF1). An essen-
tial role of zinc finger proteins in the regulation of osteo-
blast differentiation and bone remodeling has also recently
emerged. For example, ZFP521 acts as a co-factor of
Runx2 and the Runx2/ZFP521 balance regulates bone
homeostasis [53]. ZNF384 regulates expression of type I
collagen, counteracts BMP2-enhanced osteoblast differen-
tiation as well as PTH induced MMP-13 expression [54].
Our data supports a role of miRNA in a constitutive bone
defect associated with a predisposition to OC, including
impaired bone remodeling and bone cells homeostasis.
To investigate the role of miRNAs in mechanotrans-
duction pathways in bone and cartilage, samples were
subjected to a 24-hours experimental loading treatment.
The comparative analysis between unloaded and loaded
samples made it possible to identify modulated miRNAs
in cartilage and in bone. Regulation of mechanotrans-
duction pathways in articular cartilage by miRNAs was
previously suggested in a study performed with bovine
articular cartilage [12]. This study allowed for the iden-
tification of additional miRNAs (mir-17-3p, mir-874-3p)
as well as 17 new ones involved in response to mechan-
ical stress. This work is the first to demonstrate a role of
miRNAs in the regulation of mechanotransduction
pathways in bone.
Conclusions
In conclusion, based on the miRNome, equine OC ap-
pears to be associated with combined cartilage and bone
defects, in good agreement with our previous prelimin-
ary proteomics findings [55]. The precise mechanisms
linking cartilage and bone defects remain to be eluci-
dated. Moreover, cartilage and subchondral bone serve
as a functional unit to maintain joint homeostasis and a
disruption or modification of either of these two tissues
may lead to the remodeling of the other (for review see
[56]). Nevertheless, factors involved in this interaction
remain unknown. miRNAs are secreted in both tissues
and may able to take part in the communication from
cartilage to bone and from bone to cartilage through the
synovial fluid. In fact, miRNAs are present in synovial
fluid and their expression is modified in pathological sit-
uations such as OA [17]. We observed miRNAs diffe-
rentially expressed between healthy and OC cartilage
and bone, some of which should constitute relevant OC
biomarkers in synovial fluid and, to a lesser extent, in
plasma.
Finally, there is no evidence indicating that identified
defects could alone be sufficient to induce OC lesions.
Since biomechanical constraints are thought to trigger
the development of focal lesions, we also explored the
hypothesis of an impaired response to biomechanical
constraint and some mild differences could beobserved between healthy and predisposed samples.
However, it remains unclear whether these differences
may reflect a constitutively impaired response to bio-
mechanical constrains or may reflect changes in ECM
structure and biomechanical properties, consequently
modifying mechanical signal transduction and leading
to a slightly different outcome.
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Additional file 1: Figure S1. Histological analysis of OC lesions. Upper
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and embedded in paraffin. 5-μm sections were stained with safranin O-Light
Green (LGS). Irregularities and reduced thickness were observed at the
cartilage surface. The absence of staining both in and close to the lesion
indicates reduction in proteoglycan content suggesting that cartilage is
composition is modified. Abnormal cartilage cores were also observed into
the subchondral bone which may reflect an abnormal bone maturation
process.
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